Cite
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study
MLA
Patrizia Pizzichini, et al. Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e3c2208a24b41c82f1e83491c5cbacb2&authtype=sso&custid=ns315887.
APA
Patrizia Pizzichini, Francesca Perrone Congedi, Flavia De Giacomo, Giuseppe Facondo, Mattia Falchetto Osti, Maria Christina Cox, Sabrina Pelliccia, Agostino Tafuri, Alice Di Rocco, Vitaliana De Sanctis, Marco Alfò, Dimitri Anzellini, Maurizio Valeriani, Maria Massaro, Daniela Prosperi, Maurizio Martelli, & Gianluca Vullo. (2020). Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.
Chicago
Patrizia Pizzichini, Francesca Perrone Congedi, Flavia De Giacomo, Giuseppe Facondo, Mattia Falchetto Osti, Maria Christina Cox, Sabrina Pelliccia, et al. 2020. “Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e3c2208a24b41c82f1e83491c5cbacb2&authtype=sso&custid=ns315887.